Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBA of Macozinone in Pulmonary Tuberculosis
NCT03334734Phase 2Terminated
- Sponsor
- Nearmedic Plus
- Start
- Dec 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of macozinone in pulmonary tuberculosis (TB), sponsored by Nearmedic Plus. Started Dec 2016; status: terminated.
02
Drugs
macozinone
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT03334734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334734.